Detailed information for compound 1768909

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 306.385 | Formula: C17H14N4S
  • H donors: 1 H acceptors: 3 LogP: 3.85 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: c1ccc(cc1)CCc1nnc(s1)c1ccc2c(c1)nc[nH]2
  • InChi: 1S/C17H14N4S/c1-2-4-12(5-3-1)6-9-16-20-21-17(22-16)13-7-8-14-15(10-13)19-11-18-14/h1-5,7-8,10-11H,6,9H2,(H,18,19)
  • InChiKey: RTWPGCQKPUAQPX-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens glutaminyl-peptide cyclotransferase-like No references
Homo sapiens glutaminyl-peptide cyclotransferase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_129821 All targets in OG5_129821
Schistosoma mansoni glutaminyl cyclase (M28 family) Get druggable targets OG5_129821 All targets in OG5_129821
Schistosoma japonicum ko:K00683 glutaminyl-peptide cyclotransferase [EC2.3.2.5], putative Get druggable targets OG5_129821 All targets in OG5_129821
Echinococcus multilocularis glutaminyl peptide cyclotransferase Get druggable targets OG5_129821 All targets in OG5_129821
Brugia malayi Peptidase family M28 containing protein Get druggable targets OG5_129821 All targets in OG5_129821
Echinococcus granulosus glutaminyl peptide cyclotransferase Get druggable targets OG5_129821 All targets in OG5_129821
Onchocerca volvulus Glutaminyl cyclase homolog Get druggable targets OG5_129821 All targets in OG5_129821

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus endoplasmic reticulum metallopeptidase 1 glutaminyl-peptide cyclotransferase 361 aa 292 aa 21.9 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni NADP-specific isocitrate dehydrogenase 0.1083 1 1
Onchocerca volvulus Glutaminyl cyclase homolog 0.018 0.0508 0.5
Mycobacterium tuberculosis Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) 0.1083 1 1
Trypanosoma cruzi isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.1083 1 1
Schistosoma mansoni DNA topoisomerase type I 0.0161 0.0308 0.0308
Echinococcus multilocularis DNA topoisomerase 1 0.0215 0.0876 0.0876
Loa Loa (eye worm) hypothetical protein 0.018 0.0508 0.0508
Brugia malayi DNA topoisomerase I 0.0215 0.0876 0.0876
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.1083 1 1
Echinococcus granulosus glutaminyl peptide cyclotransferase 0.018 0.0508 0.0508
Schistosoma mansoni glutaminyl cyclase (M28 family) 0.018 0.0508 0.0508
Brugia malayi Isocitrate dehydrogenase 0.1083 1 1
Trypanosoma brucei isocitrate dehydrogenase, putative 0.1083 1 1
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.1083 1 1
Echinococcus granulosus NADP dependent isocitrate dehydrogenase 0.1083 1 1
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.1083 1 1
Toxoplasma gondii isocitrate dehydrogenase 0.1083 1 1
Mycobacterium leprae PROBABLE 3-ISOPROPYLMALATE DEHYDROGENASE LEUB (BETA-IPM DEHYDROGENASE) (IMDH) (3-IPM-DH) 0.0132 0 0.5
Loa Loa (eye worm) DNA topoisomerase I 0.0215 0.0876 0.0876
Leishmania major isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.1083 1 1
Trypanosoma cruzi isocitrate dehydrogenase, putative 0.1083 1 1
Mycobacterium ulcerans 3-isopropylmalate dehydrogenase 0.0132 0 0.5
Trichomonas vaginalis isocitrate dehydrogenase, putative 0.0132 0 0.5
Plasmodium falciparum isocitrate dehydrogenase [NADP], mitochondrial 0.1083 1 1
Echinococcus multilocularis isocitrate dehydrogenase 0.1083 1 1
Entamoeba histolytica tartrate dehydrogenase, putative 0.0132 0 0.5
Loa Loa (eye worm) isocitrate dehydrogenase 0.1083 1 1
Toxoplasma gondii isocitrate dehydrogenase 0.1083 1 1
Wolbachia endosymbiont of Brugia malayi isocitrate dehydrogenase 0.0132 0 0.5
Echinococcus multilocularis isocitrate dehydrogenase 2 (NADP+) 0.1083 1 1
Plasmodium vivax isocitrate dehydrogenase [NADP], mitochondrial, putative 0.1083 1 1
Trypanosoma brucei isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.1083 1 1
Schistosoma mansoni DNA topoisomerase type I 0.0161 0.0308 0.0308
Leishmania major DNA topoisomerase IB, large subunit 0.0161 0.0308 0.0308
Echinococcus multilocularis glutaminyl peptide cyclotransferase 0.018 0.0508 0.0508
Schistosoma mansoni DNA topoisomerase type I 0.0215 0.0876 0.0876
Echinococcus granulosus DNA topoisomerase 1 0.0215 0.0876 0.0876
Brugia malayi Peptidase family M28 containing protein 0.018 0.0508 0.0508

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 640 nM Spectrophotometric Assay BINDINGDB. No reference
IC50 (binding) = 2.38 uM Inhibition of human glutaminyl cyclase expressed in Escherichia coli DH5alpha using H-Gln-AMC as substrate by fluorometric analysis in presence of pyroglutamyl aminopeptidase ChEMBL. 23886302
Ki (binding) = 180 nM Spectrophotometric Assay BINDINGDB. No reference
Ki (binding) = 0.333 uM Inhibition of human glutaminyl cyclase expressed in Escherichia coli DH5alpha using H-Gln-AMC as substrate by fluorometric analysis in presence of pyroglutamyl aminopeptidase ChEMBL. 23886302

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.